Jeffrey Scott Riley, Director of Gain Therapeutics GANX, has filed 1 purchase and 0 sales on the open market. The latest trade was on 25/06/24.

JR

JR

Jeffrey Scott Riley

Director

Company

Gain Therapeutics GANX

First filing

23/06/26

Trades

4 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

25/06/24

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Gain TherapeuticsGANX	Open-market buy	24/03/28	24/04/01	30,000 sh	$3.86	$115,800	No record